REFERENCES
- Alexander, J. & Vickerman, K. (1975). Fusion of host cell secondary lysosomes with parasitophorous vacuoles of Leishmania mexicana-infected macrophages. Journal of Protozoology, 22, 502–508.
- Andreoli, T. E. (1974). The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes. Annals of the New York Academy of Sciences, 235, 448–468.
- Arustamyan, T. A. (1967). Treatment with monomycin of patients with acute necrotizing leishmaniasis. Vestnik Dermatologii i Venerologii, 41, 45–49. (Russian, English summary).
- Berman, J. D. (1982). In vitro susceptibility of antimony-resistant Leishmania to alternative drugs. The Journal of Infectious Diseases, 145, 279.
- Bogorad, L. (1975). Evolution of organelles and eukaryotic genomes. Science, 188, 891–898.
- Bourland-Reinart, L. & Nicoly, M. (1975). Leishmaniose cutanée: étude ultrastructure. Dermatologica, 151, 113–124.
- Chua, N. H. & Luck, D. J. L. (1974). Biosynthesis of organelle ribosomes. In Ribosomes, eds. Nomura, M., Tissieves, A. & Lengyel, P., pp. 519–539. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
- Crofts, M. A. J. (1976). Use of amphotericin B in mucocutaneous leishmaniasis. Journal of Tropical Medicine and Hygiene, 79, 111–113.
- Durado, H. V., Borborema, C. T., Alecrin, W. & Tlahari, S. (1975). American cutaneous leishmaniasis; treatment with rifampicin. Revista Brasiliera Clinica e Terapeutica, 4, 1–6.
- El-Din Salem, M. M. & Kandil, E. (1972). Rifampicin in the treatment of cutaneous leishmaniasis. Journal of Medical Association, 6, 159–166.
- El-On, J., Pearlman, E., Schnur, L. F. & Greenblatt, C. L. (1983). Chemotherapeutic activity of rifampicin on leishmanial amastigotes and promastigotes in vitro. Israel Journal of Medical Sciences, 19, 240–245.
- Even-Paz, Z., Weinrauch, L., Livshin, R., El-On, J. & Greenblatt, C. L. (1982). Rifampicin treatment of cutaneous leishmaniasis. International Journal of Dermatology, 21, 110–112.
- Gale, E. F., Cundliffe, E., Reynolds, P. E., Richmond, M. H. & Waring, M. J. (1972). The Molecular Basis of Antibiotic Action. New York: John Wiley and Sons.
- Ganor, S. (1967). Treatment of leishmaniasis recidivans with local injection of amphotericin B. International Journal of Dermatology, 6, 141–143.
- Hamilton-Miller, J. M. T. (1973). Chemistry and biology of the polyene macrolide antibiotics. Bacteriological Reviews, 37, 166–196.
- Harrison, R. & Lunt, G. G. (1975). Biological Membranes, Their Structure and Function, pp. 202–209. Glasgow and London: Blackie.
- Hentzer, E. & Kobayasi, T. (1977). The ultrastructural changes of Leishmania tropica after treatment with pentamidine. Annals of Tropical Medicine and Parasitology, 71, 157–166.
- Holz, R. W. (1974). The effect of the polytene antibiotics nystatin and amphotericin B on their lipid membranes. Annals of the New York Academy of Sciences, 235, 469–479.
- Iskander, I. O. (1978). Rifampicin in cutaneous leishmaniasis. Journal of International Medical Research, 6, 280–285.
- Jadin, J. B. (1969). Les Rifamycines. Développements recents en ‘La Rifampicine’. Bulletin des Séances de l'Academie Royale des Sciences d'Outre Mer, 3, 582–599.
- Kissling, M. & Bergamini, N. (1981). Rifampicin in free combination with other antimicrobial drugs in non-TB infections. Chemotherapy, 27, 368–402.
- Kitahara, M., Kobayashi, G. S. & Medoff, G. (1976). Enhanced efficacy of amphotericin B and rifampicin combined in the treatment of murine histoplasmosis and blastomycosis. Journal of Infectious Diseases, 1334, 633–668.
- Long, M. W., Dixie, E., Snider, J. R. & Farer, L. S. (1979). U.S. public health services cooperative trial of three rifampicin-isonazid regimens in treatment of pulmonary tuberculosis. American Review of Respiratory Disease, 119, 879–894.
- Lou, P., Kazdan, J., Bannattaye, R. M. & Cheung, R. (1977). Successful treatment of Candida endophthalmitis with a synergistic combination of amphotericin B and rifampicin. American Journal of Ophthalmology, 83, 12–15.
- McALPINE, J. (1970). Electronic cytochemical demonstration of a lysosome in Leishmania donovani. Transactions of the Royal Society of Tropical Medicine and Hygiene, 64, 822–825.
- Peters, W., Lainson, R., Shaw, J. J., Robinson, B. L. & França LeĀo, A. (1981). Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis. Lancet, i, 1122–1123.
- Ribner, B., Kensch, G. T., Hanna, B. A. & Perloff, M. (1976). Combination amphotericin B—Rifampicin therapy for pulmonary aspergillosis in a leukemic patient. Chest, 70, 681–683.
- Sergiev, V. P. A. (1968). Repeated injections of zoonotic cutaneous leishmaniasis of acutely necrotizing type (Borovsky disease) with monomycin. Vestnik Dermatologii i Venerologii, 42, 74–76.
- Simpson, L. & Simpson, A. M. (1978). Kinetoplast RNA of Leishmania tarentolae. Cell, 14, 169–178.
- Van Der Meulen, J., Mock, B., Fekete, R. & Sarojini, P. A. (1981). Limited therapeutic action of rifampicin/isoniazid against Leishmania aethiopica. Lancet, ii, 197–198.
- Vasquez, F. R. (1977). Rifampicin in leishmaniasis. Archives of Dermatology, 113, 1610–1611.
- White, S. W., Hendricks, L. D. & Chulay, J. D. (1980). Leishmaniasis: a case history and treatment failure with rifampicin. Archives of Dermatology, 116, 620.